Novel therapeutic targets for amyotrophic lateral sclerosis: ribonucleoproteins and cellular autonomy.

Moving forward, an effective strategy could be achieved by a poly-therapeutic approach which targets both deregulated RNA metabolism and protein dyshomeostasis in the relevant cell types, at the appropriate phase of disease.